This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 03/04/2022
Location: Virtual
Subject: FDA's Rare Disease Day 2022
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, media, industry and other registered guests

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 03/02/2022
Location: Virtual
Subject: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Trial Oversight Committee Meeting
FDA Participant/Group: Peter Stein
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/02/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Joel Harris, Maria Velissariou, Peter Rowan (Mars);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/03/2022
Location: Virtual
Subject: Potential Clinical Trial Disruptions in Ukraine, Belarus and Russia Due to Russian Invasion of Ukraine Meeting
FDA Participant/Group: SANDRA KWEDER, RITU NALUBOLA
Non FDA Participant/Group: Several members of the Association of Clinical Research Organizations

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/04/2022
Location: Virtual
Subject: Horasis USA Meeting - Shaping America's Role in a Post-Pandemic World; Plenary Session - Addressing the COVID Pandemic and Preparing for the Next Wave
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Horasis USA Meeting - Shaping America's Role in a Post-Pandemic World

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/01/2022
Location: Virtual
Subject: Medical Device Information Analysis and Sharing Updates
FDA Participant/Group: ERIN KEITH; OWEN FARIS; FRANCISCO VICENTY; WILLIAM MAISEL;
Non FDA Participant/Group: Angie Hinzey , Ed Walsh, Eva Katcher, Heather Hawley, Iris Sherman, Meredith Keybl, Pam Douglas (The MITRE Corporation);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 03/04/2022
Location: Teleconference
Subject: Nutrition Issues of Mutual Interest
FDA Participant/Group: DOUGLAS STEARN; KARI BARRETT;
Non FDA Participant/Group: Peter Lurie (Center for Science and the Public Interest );

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/03/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: ISAAC CARNEY; JEANETTE MURPHY; CHARLOTTE CONWAY; TRACEY FORFA; DAVID EDWARDS; LINDA BENJAMIN; WILLIAM FLYNN; TIMOTHY SCHELL;
Non FDA Participant/Group: Several members of the American Feed Industry Association (AFIA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event